OPRX - OptimizeRx Corporation
NEXT EARNINGS:
Mar 5, 2026
(in 8 days)
EPS Est: $0.23
|
Rev Est: $30.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$23.00
LOW:
$23.00
MEDIAN:
$23.00
CONSENSUS:
$23.00
UPSIDE:
201.05%
Market Cap:
142.41M
Volume:
299,242
Avg Volume:
304,355
52 Week Range:
3.99-22.25
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
1.16
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
128
IPO Date:
2007-11-28
EPS (TTM):
-1.10
P/E Ratio:
-4.42
Revenue (TTM):
92.13M
Total Assets:
171.17M
Total Debt:
33.19M
Cash & Equiv:
13.38M
Rev Growth (5Y):
30.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
31.2%
ROCE:
-8.7%
Debt/Equity:
0.28
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.20 | $0.03 | +566.7% | $26.1M | $30.9M | -15.7% |
| 2025-08-07 | $0.24 | $0.03 | +700.0% | $29.2M | $23.8M | +22.5% |
| 2025-05-12 | $0.08 | $-0.11 | +172.7% | $21.9M | $18.7M | +17.4% |
| 2025-03-12 | $0.30 | $0.25 | +20.0% | $32.3M | $18.8M | +72.1% |
| 2024-11-13 | $0.12 | $0.06 | +100.0% | $21.3M | $30.2M | -29.4% |
| 2024-08-08 | $0.02 | $-0.07 | +128.6% | $18.8M | $20.2M | -6.8% |
| 2024-04-16 | $0.26 | $-0.13 | +300.0% | $19.7M | $18.1M | +8.6% |
| 2024-03-28 | $0.26 | $0.32 | -18.8% | $28.4M | $26.5M | +7.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.13M | 71.52M | 62.45M | 61.29M | 43.31M | 24.60M | 21.21M | 12.13M | 7.75M | 7.22M | 6.50M | 4.96M |
| Net Income | (20.11M) | (17.57M) | (11.44M) | 378,079 | (2.21M) | (3.14M) | 226,344 | (2.10M) | (1.54M) | (595,140) | (1.03M) | 215,847 |
| EPS | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | 0.02 | -0.21 | -0.16 | -0.07 | -0.14 | -0.06 |
| Total Assets | 171.17M | 183.37M | 134.65M | 140.99M | 60.33M | 56.64M | 25.05M | 9.76M | 11.48M | 12.31M | 7.03M | 4.01M |
| Total Debt | 33.19M | 36.82M | 234,434 | 327,708 | 448,753 | 564,184 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 13.38M | 13.85M | 18.21M | 84.68M | 10.52M | 18.85M | 8.91M | 5.12M | 7.03M | 8.21M | 3.45M | 1.12M |
| Operating Cash Flow | 4.89M | (7.24M) | 10.65M | 726,039 | (6.31M) | (1.66M) | 792,555 | (1.48M) | (465,965) | 515,110 | (56,350) | 1.13M |
| Free Cash Flow | 4.78M | (8.11M) | 10.41M | 240,040 | (6.44M) | (3.25M) | 701,542 | (1.52M) | (815,503) | 414,146 | (466,302) | 833,980 |
| FCF per Share | 0.26 | -0.47 | 0.59 | 0.01 | -0.43 | -0.24 | 0.06 | -0.16 | -0.08 | 0.05 | -0.06 | 0.17 |
| Book Value | 117.00M | 126.55M | 126.11M | 131.38M | 49.97M | 44.86M | 18.46M | 6.22M | 7.81M | 8.94M | 4.61M | 2.04M |
| Cash & ST Investments | 13.38M | 13.85M | 74.14M | 84.68M | 10.52M | 18.85M | 8.91M | 5.12M | 7.03M | 8.21M | 3.45M | 1.12M |
| ROC Equity | -0.17 | -0.14 | -0.09 | 0.00 | -0.04 | -0.07 | 0.01 | -0.34 | -0.20 | -0.07 | -0.22 | 0.11 |